Regulation and tissue distribution of the human sodium iodide symporter gene
- 1 October 1998
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 49 (4) , 517-523
- https://doi.org/10.1046/j.1365-2265.1998.00570.x
Abstract
OBJECTIVE Iodide uptake by the thyroid gland is mediated by the sodium iodide symporter (NIS). In the present report, we have analysed the factors that modulate human NIS mRNA expression and iodide uptake in primary thyroid follicular cell (TFC) cultures. In addition, NIS mRNA tissue distribution was investigated. METHODS Primary thyroid follicular cell cultures were treated with human recombinant TSH with or without cytokines for 72 h. Subsequently, NIS gene expression and iodide uptake were analysed using reverse transcription–polymerase chain reaction (RT–PCR) and 125I uptake, respectively. Human tissue samples were investigated for NIS gene expression using both RT–PCR and Northern blotting. RESULTS Human TSH increased both NIS gene expression and iodide uptake in TFC cultures in a dose‐dependent manner. Using concentrations of 0.1 U/l of hTSH, a minor increase in NIS gene expression was detected without a detectable increase in iodide uptake. IL‐1α,TNFα and IFNγ at concentrations of 105 U/l all inhibited TSH‐induced NIS gene expression and iodide uptake. In these experiments, there was a good correlation between NIS mRNA expression and iodide uptake. Using RT–PCR higher levels of NIS mRNA were detected in Graves' disease (GD) compared to multi‐nodular goitre tissue samples. Stomach and salivary gland tissue also expressed NIS mRNA, whereas low levels were found in the mammary gland and extraocular muscle tissue. No expression was detected in the ovary, oesophagus, colon, extraocular fat or skin. In contrast, Northern blot analysis failed to detect NIS in stomach, salivary gland, intestinal fat or non‐toxic multi‐nodular goitre tissue samples, although this was present in GD thyroid tissue. CONCLUSION TSH upregulates sodium iodide symporter gene expression and iodide uptake in primary thyroid follicular cell cultures, and this induction is modulated by cytokines. Variable levels of sodium iodide symporter mRNA are present in different tissue samples, with high expression evident in Graves' disease thyroid tissue.Keywords
This publication has 24 references indexed in Scilit:
- The sodium iodide symporter gene and its regulation by cytokines found in autoimmunityJournal of Endocrinology, 1998
- The Modulation of the Human Sodium Iodide Symporter Activity by Graves' Disease SeraJournal of Clinical Endocrinology & Metabolism, 1998
- Binding of Immunoglobulin G from Patients with Autoimmune Thyroid Disease to Rat Sodium-Iodide Symporter Peptides: Evidence for the Iodide Transporter as an Autoantigen*Thyroid®, 1997
- Cloning of the Human Sodium Iodide SymporterBiochemical and Biophysical Research Communications, 1996
- Autoantibody against Na+/I−Symporter in the Sera of Patients with Autoimmune Thyroid DiseaseBiochemical and Biophysical Research Communications, 1996
- Semi-quantitative analysis of interleukin-1α, interleukin-6 and interleukin-8 mRNA expression by human thyrocytesJournal of Molecular Endocrinology, 1995
- Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathyClinical Endocrinology, 1995
- Transforming growth factor-β1 synthesis in human thyroid follicular cells: differential effects of iodide and plasminogen on the production of latent and active peptide formsJournal of Endocrinology, 1994
- Iodide transport in the thyroid glandBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Suppression of Rat Thyrotroph and Thyroid Cell Function by Tumor Necrosis Factor-αThyroid®, 1993